Selective estrogen receptor modulation prevents scoliotic curve progression: radiologic and histomorphometric study on a bipedal C57Bl6 mice model
نویسندگان
چکیده
منابع مشابه
Selective estrogen receptor modulation: a personal perspective.
Professor Paul Ehrlich is the father of experimental chemotherapy. During the first decade of the 20th Century, he reasoned that compounds could be synthesized to exhibit selective toxicity on a parasite without affecting the host. The synthesis, laboratory evaluation, and clinical development of Salvarsan, the 606th compound tested, revolutionized the treatment of syphilis, which was at the ti...
متن کاملConvex side muscular activity and progression of scoliotic curve
Results Increased paraspinal muscular activity at convex side of scoliotic curve is well known and documented finding. Main directions of research are related to structural changes in muscles and regulation of muscular contractility. In most cases the myopathic changes are considered as the consequence of the postural deformity. Very little information is available on the mechanisms by which su...
متن کاملa study on insurer solvency by panel data model: the case of iranian insurance market
the aim of this thesis is an approach for assessing insurer’s solvency for iranian insurance companies. we use of economic data with both time series and cross-sectional variation, thus by using the panel data model will survey the insurer solvency.
The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
Despite the effectiveness of the selective estrogen receptor (ER) modulators in preventing ER-positive breast cancer, chemopreventive agents still need to be developed for the prevention of ER-negative breast cancers. The naturally occurring retinoids are promising agents for the prevention of human cancers but are too toxic for long-term chronic use. We previously demonstrated that the chemopr...
متن کاملEstrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.
In terms of lifetime risk, one in three women will die of heart disease and one in six of stroke; in contrast, one in nine women will develop breast carcinoma, and only one in 25 will eventually die of it (1). It is, therefore, clear that a successful therapeutic intervention to improve death rates for coronary heart disease (CHD), however modest, will have a disproportionately large benefit on...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Spine Journal
سال: 2013
ISSN: 0940-6719,1432-0932
DOI: 10.1007/s00586-013-3072-2